Skip to main content
Quest Diagnostics
Get in touch
Call
Menu

Dignity Health delivers care with compassion. We share your mission—especially when it comes to hereditary cancer diagnostics

BRCA testing is just the beginning. Many eligible patients remain untested for hereditary cancer—and primary care plays a critical role in closing that gap. Together, we can expand access to comprehensive testing and help more patients take informed action—without adding complexity to your workflow.

Our solutions go further, so Dignity Health's care can too

 

Our comprehensive and guideline-based hereditary cancer panels include multi-gene panels and single-site tests, covering over 100 genes

A robust portfolio of disease- and condition-specific hereditary cancer tests helps complete the diagnostic picture

We offer syndrome-specific tests that analyze genes that can be associated with different cancer syndromes, including Lynch syndrome, hereditary breast and ovarian cancer syndrome, familial adenomatous polyposis (FAP), and others

Qualified tests are provided at no charge or reduced for uninsured or underinsured patients who qualify—so financial considerations won’t hinder diagnostic care

Click to download our hereditary cancer brochure  >

As your partner, Quest offers comprehensive testing panels for patients who face an increased risk for hereditary breast or ovarian cancers, including

  • Tests for variants in 18 genes predominantly associated with breast, prostate, and other tissue cancers
  • Comprehensive panel test code: 38600
  • Guideline panel test code: 38611

Genes included: ATM, BARD1, BRCA1, BRCA2, CDH1, CHEK2, EPCAM, MLH1, MSH2, MSH6, NF1, PALB2, PMS2, PTEN, RAD51C, RAD51D, STK11, TP53

  • Detects variants in 7 genes associated specifically with breast cancer
  • Test code: 92587

Genes included: BRCA1, BRCA2, CDH1, PALB2, PTEN, STK11, TP53

We have created reports to aid in discussions with your patients about their hereditary cancer test results.

Learn more
*Criteria based on NCCN guidelines.

Sharing your mission: Solutions designed to improve operational efficiency and clinical outcomes

Enhanced coordination between labs and providers can ensure seamless patient journeys, no matter where a patient receives care. We provide tools that support integrated care efforts and facilitate communication and coordination across teams.

Fully integrated diagnostics

Integrated lab data within EHRs allows providers to monitor outcomes and regulatory metrics

Actionable clinical insights

Leveraging data analytics to provide clear, actionable insights that enhance decision-making and help to improve patient outcomes

Streamlined laboratory services

By consolidating and centralizing lab operations, we help practices reduce redundancies, enhance operational efficiency, and achieve cost savings at scale

Strengthening collaboration in care

We enhance the patient journey by seamlessly integrating with physician workflows, leveraging proactive health insights, and fostering partnerships that elevate patient care coordination and outcomes

Excellence in hereditary cancer screening

Quest’s full-service approach, including ~2,400 Patient Service Centers, is designed to support practices and their patients at every step—from screening and ordering to pre-authorization, sample analysis, and results interpretation.

 

Need additional assistance?

• Our board-certified genetic counselors, medical geneticists, and medical directors are available to you daily from 5:30 AM to 5:00 PM PST, online or by phone

• Call 1.866.GENE.INFO for answers, reports, results interpretation, and post-test consultation

Let us help support your enhanced care with hereditary cancer screening

Whether you have questions about our offerings or are interested in working with Quest to support your practice, our dedicated Account Team is here to help.

855

* indicates required

Reference:

1. Childers CP, Childers KK, Maggard-Gibbons M, et al. National estimates of genetic testing in women with a history of breast or ovarian cancer. J Clin Oncol. 2017;35(34):3800-3806. doi: 10.1200/JCO.2017.73.6314

Our company

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.